ZenBio's IPO Soars 158% on First Trading Day, With Global Offering of 33.44 Million H-Shares at HK$12.90
ZenBio\'s IPO soars, with a current rise exceeding 12%, priced at HK$37.5, and yesterday\'s market performance surged 158%.
ZenBio's IPO soars, with a current rise exceeding 12%, priced at HK$37.5, and yesterday's market performance surged 158%.
ZenBio's latest global offering of H-shares totals 33.44 million shares, with a final listing price of HK$12.90, which falls within the issuance price range, and the total funds raised amount to approximately HK$4.31 billion. The funds raised from this IPO will primarily be used for the development and registration of its core products in China and abroad; research and development of other vaccine candidates; and improvement of processes and commercialization capabilities.